Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PRTK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PRTK

  • Market Cap$280.630m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS6993743029

Company Profile

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.

Latest PRTK news

Currently there for this company. Visit our news hub for other news .